119 related articles for article (PubMed ID: 14527874)
1. A bifunctional alkylating nitrogen mustard agent that utilizes barbituric acid as carrier drug with the potential for crossing the brain-blood barrier.
Bartzatt R; Donigan L
Recept Channels; 2003; 9(5):309-13. PubMed ID: 14527874
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and alkylation activity of a nitrogen mustard agent to penetrate the blood-brain barrier.
Bartzatt RL
Drug Deliv; 2004; 11(1):19-26. PubMed ID: 15168787
[TBL] [Abstract][Full Text] [Related]
3. Utilizing a D-amino acid as a drug carrier for antineoplastic nitrogen mustard groups.
Bartzatt RL
Drug Deliv; 2005; 12(3):141-7. PubMed ID: 16025843
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of aromatic nitrogen mustard agents and analysis of their alkylation activity at physiological pH and temperature.
Bartzatt R; Kasher L
Physiol Chem Phys Med NMR; 2002; 34(2):103-17. PubMed ID: 12841328
[TBL] [Abstract][Full Text] [Related]
5. Bifunctional constructs of aspirin and ibuprofen (non-steroidal anti-inflammatory drugs; NSAIDs) that express antibacterial and alkylation activities.
Bartzatt R; Cirillo SL; Cirillo JD; Donigan L
Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):273-82. PubMed ID: 12533193
[TBL] [Abstract][Full Text] [Related]
6. Alkylation activity and molecular properties of two antineoplastic agents that utilise indometacin and a conjugate of aspirin with 2-aminonicotinic acid to transport nitrogen mustard groups.
Bartzatt R
Drugs R D; 2007; 8(6):363-72. PubMed ID: 17963427
[TBL] [Abstract][Full Text] [Related]
7. Two lead drug designs based on chloramphenicol as the parent structure, which express alkylation activity with potential for clinical applications.
Bartzatt R
J Pharm Pharmacol; 2003 May; 55(5):653-60. PubMed ID: 12831508
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structural analysis and antibacterial activity of a butyl ester derivative of ampicillin.
Bartzatt R; Malesa C
Chemotherapy; 2003 Sep; 49(5):213-21. PubMed ID: 14504431
[TBL] [Abstract][Full Text] [Related]
9. Multimodal inclusion complexes between barbiturates and 2-hydroxypropyl-beta-cyclodextrin in aqueous solution: isothermal titration microcalorimetry, (13)C NMR spectrometry, and molecular dynamics simulation.
Aki H; Niiya T; Iwase Y; Yamamoto M
J Pharm Sci; 2001 Aug; 90(8):1186-97. PubMed ID: 11536223
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and reactivity of aryl nitrogen mustard-oligodeoxyribonucleotide conjugates.
Reed MW; Lukhtanov EA; Gorn V; Kutyavin I; Gall A; Wald A; Meyer RB
Bioconjug Chem; 1998; 9(1):64-71. PubMed ID: 9460548
[TBL] [Abstract][Full Text] [Related]
11. Substituent effects on partition coefficients of barbituric acids.
Wong O; McKeown RH
J Pharm Sci; 1988 Nov; 77(11):926-32. PubMed ID: 3225751
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of new benzoheterocyclic derivatives of distamycin A.
Baraldi PG; Romagnoli R; Beria I; Cozzi P; Geroni C; Mongelli N; Bianchi N; Mischiati C; Gambari R
J Med Chem; 2000 Jul; 43(14):2675-84. PubMed ID: 10893305
[TBL] [Abstract][Full Text] [Related]
13. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.
Bramson J; McQuillan A; Aubin R; Alaoui-Jamali M; Batist G; Christodoulopoulos G; Panasci LC
Mutat Res; 1995 May; 336(3):269-78. PubMed ID: 7739615
[TBL] [Abstract][Full Text] [Related]
14. Alkylating properties of phosphoramide mustard.
Colvin M; Brundrett RB; Kan MN; Jardine I; Fenselau C
Cancer Res; 1976 Mar; 36(3):1121-6. PubMed ID: 1253171
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship for alkylating dipeptide nitrogen mustard derivatives.
Gullbo J; Tullberg M; Våbenø J; Ehrsson H; Lewensohn R; Nygren P; Larsson R; Luthman K
Oncol Res; 2003; 14(3):113-32. PubMed ID: 14760861
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis of a potential metabolite of the carcinostatic bendamustin (Cytostasen)].
Werner W; Letsch G; Ihn W; Sohr R; Preiss R
Pharmazie; 1991 Feb; 46(2):113-4. PubMed ID: 1852759
[TBL] [Abstract][Full Text] [Related]
17. Thermodynamic dependence of interfacial transfer kinetics of nonionized barbituric acid derivatives in two-phase transfer cell.
Byron PR; Guest RT; Notari RE
J Pharm Sci; 1981 Nov; 70(11):1265-9. PubMed ID: 7299674
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, DNA sequence preferential alkylation and biological evaluation of N-mustard derivatives of distamycin and netropsin analogues.
Xie G; Gupta R; Lown JW
Anticancer Drug Des; 1995 Jul; 10(5):389-409. PubMed ID: 7639929
[TBL] [Abstract][Full Text] [Related]
19. DNA-directed alkylating agents. 6. Synthesis and antitumor activity of DNA minor groove-targeted aniline mustard analogues of pibenzimol (Hoechst 33258).
Gravatt GL; Baguley BC; Wilson WR; Denny WA
J Med Chem; 1994 Dec; 37(25):4338-45. PubMed ID: 7527862
[TBL] [Abstract][Full Text] [Related]
20. Optimization of alkylating agent prodrugs derived from phenol and aniline mustards: a new clinical candidate prodrug (ZD2767) for antibody-directed enzyme prodrug therapy (ADEPT).
Springer CJ; Dowell R; Burke PJ; Hadley E; Davis DH; Blakey DC; Melton RG; Niculescu-Duvaz I
J Med Chem; 1995 Dec; 38(26):5051-65. PubMed ID: 8544182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]